Shayne & Jacobs LLC Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Shayne & Jacobs LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,550 shares of the healthcare conglomerate’s stock after selling 90 shares during the quarter. UnitedHealth Group comprises 0.8% of Shayne & Jacobs LLC’s holdings, making the stock its 23rd largest position. Shayne & Jacobs LLC’s holdings in UnitedHealth Group were worth $2,355,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group during the first quarter worth $42,000. Kentucky Trust Co increased its stake in UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after acquiring an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 37 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 3.6%

UNH opened at $354.30 on Friday. The business has a fifty day moving average price of $318.21 and a 200 day moving average price of $350.41. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.38 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The firm’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Mizuho lifted their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Barclays lifted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.